{"title":"在 T 细胞和巨噬细胞之间建立联盟，增强癌症免疫疗法。","authors":"Tessa Gargett, Lisa M Ebert","doi":"10.1111/imcb.12799","DOIUrl":null,"url":null,"abstract":"<p>A new study by Yamada-Hunter <i>et al.</i> reveals a novel approach to promote synergy—rather than antagonism—between macrophages and engineered T cells, leading to enhanced antitumor immunity.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12799","citationCount":"0","resultStr":"{\"title\":\"Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy\",\"authors\":\"Tessa Gargett, Lisa M Ebert\",\"doi\":\"10.1111/imcb.12799\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A new study by Yamada-Hunter <i>et al.</i> reveals a novel approach to promote synergy—rather than antagonism—between macrophages and engineered T cells, leading to enhanced antitumor immunity.</p>\",\"PeriodicalId\":179,\"journal\":{\"name\":\"Immunology & Cell Biology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12799\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology & Cell Biology\",\"FirstCategoryId\":\"2\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12799\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12799","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
Yamada-Hunter 等人的一项新研究揭示了一种促进巨噬细胞与工程 T 细胞之间协同作用而非拮抗作用的新方法，从而增强了抗肿瘤免疫力。
Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy
A new study by Yamada-Hunter et al. reveals a novel approach to promote synergy—rather than antagonism—between macrophages and engineered T cells, leading to enhanced antitumor immunity.
期刊介绍：
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
